{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicsqkn5pgzcl4qz27x5caimww7h4y4xib64xjfmvly6w75xzqhzfm",
    "uri": "at://did:plc:nzm6xlhdk3myu4xft63gxqp4/app.bsky.feed.post/3mlprjnta2gh2"
  },
  "path": "/markets/cohance-lifesciences-downgraded-by-icici-securities-despite-target-price-hike-after-q4-results-heres-why-11487874",
  "publishedAt": "2026-05-13T06:25:27.000Z",
  "site": "https://www.ndtvprofit.com",
  "tags": [
    "Markets"
  ],
  "textContent": "Cohance's Q4 and FY26 performance remained under pressure due to continued inventory de-stocking in two large pharma CDMO products, product-specific challenges in the API segment and a delay in the...",
  "title": "Cohance Downgraded by ICICI Securities Despite Target Price Hike After Q4 Results"
}